Build A Healthier Portfolio With These 5 Stocks

Robert Weinstein submits:AmerisourceBergen (ABC), an $8.65 billion market cap company, is a pharmaceutical services company that provides drug distribution and related services to healthcare providers and pharmaceutical manufacturers in the United States, the United Kingdom, and Canada.

Bud Labitan submitsAmerisourceBergen Corporation (ABC) is a pharmaceutical services company, with operations in the United States and Canada. Servicing both healthcare providers and pharmaceutical manufacturers in the pharmaceutical supply channel, the Company provides drug distribution and related services.

Dividend Inc. submits: Since our write-up on Cardinal Health (CAH) on September 29, 2009, the stock has appreciated 23%. Purchasing the stock on 9/30/09 for $26.80 and selling it today for $33 would yield an annualized return of 57%. This excludes two dividend payments.Let's review the numbers.

Insider Monkey submits: Arthur Cohen is a cofounder of HealthCor Management, a $2.7 billion healthcare hedge fund. Cohen graduated from the University of Virginia in 1983 with a B.A. degree in Commerce and received his M.B.A. in Banking and Finance from Hofstra University in 1986.

By Trefis: Walgreen (WAG) stock has risen almost 10% since the company announced its Q3 2013 results on Tuesday. The rise was backed by a strong performance during the quarter and the announcement of a 10-year agreement with AmerisourceBergen (ABC).

ByDeep Dives:Today's earnings announcement by Walgreen Corp (WAG) was accompanied by an additional release that sounded an ominous note for Cardinal Health (CAH) shareholders.

TORONTO — The federal health minister’s move to let drug makers voluntarily alert doctors and pharmacists of medication shortages went against concerns the approach could put Canada’s drug supply at risk, documents show. Civil servants at Health Canada warned in February of last year that the voluntary-notice option subsequently chosen by Leona Aglukkaq was “susceptible to bad company behaviour” because there would be no way to punish manufacturers who fail to report production gaps that leave health practitioners scrambling to get drugs to their patients.

By F.A.S.T. Graphs:This article looks at Fortune 500 company McKesson Corp. (MCK) through the lens of the FAST Graphs™ fundamentals analyzer software tool, which shows us that 18 leading analysts reporting to Capital IQ forecast McKesson's long-term earnings growth at 13%. The prudent growth and dividend investor may want to do their own due diligence on this company for a possible addition to their portfolio.